Acuta Capital Partners’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q1 | – | Hold |
0
| – | – | – | 64 |
|
2020
Q4 | – | Hold |
0
| – | – | – | 60 |
|
2019
Q3 | – | Sell |
-255,000
| Closed | -$11.2M | – | 39 |
|
2019
Q2 | $11.2M | Buy |
255,000
+49,000
| +24% | +$2.15M | 3.97% | 9 |
|
2019
Q1 | $10.6M | Buy |
206,000
+18,500
| +10% | +$952K | 5.04% | 6 |
|
2018
Q4 | $6.93M | Buy |
187,500
+55,000
| +42% | +$2.03M | 5.29% | 5 |
|
2018
Q3 | $4.98M | Sell |
132,500
-27,500
| -17% | -$1.03M | 1.77% | 15 |
|
2018
Q2 | $6.32M | Buy |
+160,000
| New | +$6.32M | 1.13% | 19 |
|